April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Targeting Electrophysiological Markers of Short-Wavelength Visual Pathway Dysfunction in Adolescents With Type 1 Diabetes
Author Affiliations & Notes
  • M. T. McFarlane
    Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
    Institute of Medical Science,
    University of Toronto, Toronto, Ontario, Canada
  • G. Mirabella
    Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
  • T. Wright
    Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
  • C. A. Westall
    Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada
    Ophthalmology and Vision Sciences,
    University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships  M.T. McFarlane, None; G. Mirabella, None; T. Wright, None; C.A. Westall, None.
  • Footnotes
    Support  Juvenile Diabetes Research Foundation (JDRF), Vision Science Research Program (VSRP)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3259. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. T. McFarlane, G. Mirabella, T. Wright, C. A. Westall; Targeting Electrophysiological Markers of Short-Wavelength Visual Pathway Dysfunction in Adolescents With Type 1 Diabetes. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3259.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To identify electrophysiological markers of short-wavelength loss in adolescents with Type 1 Diabetes (T1D).

Methods: : Visual evoked potentials (VEPs) were recorded to black-white luminance as well as isoluminant short-and long-medium- vertical, sinusoidal gratings (1cyc/deg) in 50 patients with T1D (15 ± 1.88 years old) and 42 controls (16 ± 3.64 years old). VEP latencies were evaluated in response to pattern onset-offset gratings (2Hz) presented at 40, 20 and 10% contrasts. Short-wavelength electroretinograms (sERGs) were recorded using blue flashes (peak 410nm) against an amber (594 nm) background in 18 of the patients with T1D (15 ± 1.53 years old) and 18 controls (17 ± 3.88 years old). The outcome measures were implicit time of the b-wave and amplitude of the photopic negative response (PhNR) measured from baseline at 100 ms. Ambient blood glucose was maintained between 4-10mmol/L before and during testing. Hemoglobin A1c (HbA1c), a measure of long-term blood glucose control, was 8.90% ± 1.38 in the patient population. Patients with Diabetic Retinopathy were excluded.

Results: : VEP latencies to short-wavelength stimuli were delayed in those with T1D compared with controls at all contrasts (repeated measures regression, p=0.004). Responses to long-medium wavelength and achromatic stimuli were not delayed significantly in those with T1D. sERG implicit times were delayed (p=0.0002) and PhNR amplitudes were decreased (p=0.03) in adolescents with T1D compared with controls. Age or HbA1c were not correlated with the ERG measures.

Conclusions: : Short-wavelength VEPs show a dysfunction in the retinal-striate short-wavelength pathway in adolescents with T1D. sERG implicit time delays identified dysfunction in the outer/middle retina while PhNR results suggest dysfunction in the inner retina. As HbA1c is a known risk factor for Diabetic Retinopathy, the lack of correlations with sERG implicit time or PhNR suggests that these outcome measures are not good biomarkers for risk of developing retinopathy.

Keywords: diabetic retinopathy • color vision • electrophysiology: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×